home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Analysis Of Four Neuroligin Genes As Candidates For Autism

 
  November, 29 2005 11:18
your information resource in human molecular genetics
 
     
Analysis Of Four Neuroligin Genes As Candidates For Autism

Tero Ylisaukko-oja (1,2), Karola Rehnström (1,2), Mari Auranen (1,2), Raija Vanhala (3), Reija Alen (4), Elli Kempas (1,2), Pekka Ellonen (1), Joni A Turunen (1), Ismo Makkonen (5), Raili Riikonen (5), Taina Nieminen-von Wendt (3), Lennart von Wendt (3), Leena Peltonen (1,2) and Irma Järvelä (2,6)

(1) Department of Molecular Medicine, National Public Health Institute, Helsinki, Finland
(2) Department of Medical Genetics, University of Helsinki, Helsinki, Finland
(3) Unit of Child Neurology, Hospital for Children and Adolescents, Helsinki, Finland
(4) Department of Child Neurology, Central Hospital of Central Finland, Jyväskylä, Finland
(5) Department of Child Neurology, Children's Hospital, University of Kuopio, Kuopio, Finland
(6) Laboratory of Molecular Genetics, Helsinki University Central Hospital, Helsinki, Finland

Neuroligins are cell-adhesion molecules located at the postsynaptic side of the synapse. Neuroligins interact with neurexins and this interaction is involved in the formation of functional synapses. Mutations in two X-linked neuroligin genes, NLGN3 and NLGN4, have recently been implicated in pathogenesis of autism. Mutation analysis of 30 probands selected from families producing linkage evidence for Xq13 and/or 3q26 loci revealed several polymorphisms, but none of these seemed to be functional (European Journal of Human Genetics, Vol. 13, pp. 1285–1292). The authors conclude that neuroligin mutations most probably represent rare causes of autism and that it is unlikely that the allelic variants in these genes would be major risk factors for autism.

Correspondence:

T Ylisaukko-oja, National Public Health Institute, Department of Molecular Medicine, Biomedicum, PO Box 104, 00251 Helsinki, Finland.
E-mail: tero.ylisaukko-oja@ktl.fi

Abstract available online.

(C) European Journal Of Human Genetics.

Posted by: Tressie Dalaya


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.